Concepedia

Younggil Kwon

YK

Statistics

Publications

9

Citations

228

H-Index

9

Active since

1996

Affiliations

Pfizer (United States)(Current)

University at Buffalo, State University of New York

Younggil Kwon is an author at Pfizer (United States) specializing in pharmacology, pharmacy, and life sciences.

Publications per year

1996–2006

9

Publications

9

Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.

Jeremy C. Parker, Maria A. VanVolkenburg, Carolyn B. Levy et al. · Diabetes · 1998 · 58 citations

, , +13

Lack of Pharmacokinetic Interaction for ISIS 113715, a 2???-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or Rosiglitazone

Richard S. Geary, JoAnn D. Bradley, Tanya Watanabe et al. · Clinical Pharmacokinetics · 2006 · 49 citations

, , +16

Inhibitors of P-Glycoprotein-Mediated Daunomycin Transport in Rat Liver Canalicular Membrane Vesicles

Younggil Kwon, Amrita V. Kamath, Marilyn E. Morris · Journal of Pharmaceutical Sciences · 1996 · 30 citations

, , +14

Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase

H. James Harwood, Stephen F. Petras, Dennis J. Hoover et al. · Journal of Lipid Research · 2004 · 21 citations · Full text

, , +12

Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors

Nacide Ercan-Fang, Miriam R. Taylor, Judith L. Treadway et al. · American Journal of Physiology-Endocrinology and Metabolism · 2005 · 18 citations

, , +15

1–5 of 9